Id: CBI_2380 | Pages: 315 | Format : PDF | Published : | Author : Amit Sati | Category : Healthcare
Aortic Aneurysm Market size is growing with a CAGR of 9.3% during the forecast period (2025-2032), and the market is projected to be valued at USD 10,852.55 Million by 2032 from USD 5,361.08 Million in 2024. Additionally, the market value for 2025 attributed to USD 5,838.53 Million.
An aortic aneurysm is a bulging in the wall of the aorta. Aorta is the body's largest artery. The aneurysm ruptures if it is not treated. This leads to life-threatening bleeding. There are three main types, thoracic aortic aneurysm, abdominal aortic aneurysm, and thoracoabdominal aortic aneurysm. Medical professionals are using ultrasound, CT scans, MRI, and angiography for the diagnosis of this condition. The treatment of this condition varies. The small dimensions of aneurysms are frequently monitored by doctors. Moreover, larger aneurysms are treated with surgery. There are two treatment options. This includes open surgical repair (OSR) and endovascular aneurysm repair (EVAR). Hospitals, clinics, and ambulatory surgery centers (ASCs) are the healthcare facilities which are providing treatments.
New medical imaging technologies are improving detection rates of aneurysms in aorta. Advanced ultrasound and 4D flow MRI machines provide real-time 3D visualization. It gives better insights into blood flow and aneurysm structure. These improvements are leading to early and safer diagnosis. Also, they are proving to be more accurate. This reduces the risk of sudden ruptures. Moreover, companies are integrating machines with advanced software as well.
For instance,
Overall, the technological advancements in diagnostic procedures are significantly boosting the aortic aneurysm market expansion.
There is an increasing aging population. Aneurysms are more common among older adults. Also, worldwide poor lifestyle factors are observed. Due to this, governments are promoting ultrasound screenings for people at higher risk. This includes men over 65, and smokers. Individuals with high blood pressure are also encouraged. Regular screening detects aneurysms early. Moreover, hospitals and healthcare organizations are also launching surveillance programs to save lives.
For instance,
Thus, increasing screening programs are accelerating the global aortic aneurysm market growth.
The market faces hurdles due to strict regulatory approvals required for medical devices and medications. Regulatory bodies such as U.S. Food and Drug Administration (FDA) and European Medicines Agency (EMA) closely monitor stent grafts, surgical tools, and new medicines. Before they get approved, companies must go through long clinical trials. This is important to prove they are safe and work well.
Even after approval, companies must provide ongoing data about patient safety. These regulations help protect patients, but they slow down innovation. It also increases treatment costs. Moreover, the regulatory process varies by country and region. This creates barriers for companies who aim for international commercialization. Hence, the stringent regulatory requirements are hampering the aortic aneurysm market demand.
Minimally invasive surgery (MIS) is a procedure that uses small incisions. Endovascular aneurysm repair (EVAR) is a popular choice among medical professionals. The main benefits include shorter recovery times and reduced risk of infection. It also causes less pain when compared to traditional. There is a growing focus on patient-centric treatments. This is leading manufacturers to focus on products that align with minimally invasive approaches.
For instance,
Overall, growing demand for minimally invasive surgery is expected to increase aortic aneurysm market opportunities.
Based on type, the market is categorized into diagnosis and treatment.
Trends in Type:
The treatment segment accounted for the largest market share in 2024 and is expected to grow at the fastest CAGR over the forecast period.
Based on aneurysm type, the market is categorized into thoracic aortic aneurysm (TAA), abdominal aortic aneurysm (AAA), and thoracoabdominal aortic aneurysm (TAAA).
Trends in Aneurysm Type:
The abdominal aortic aneurysm (AAA) segment accounted for the largest market share in 2024
The thoracic aortic aneurysm (TAA) segment is expected to grow at the fastest CAGR over the forecast period.
Based on end-use, the market is categorized into hospitals, clinics, and ambulatory surgical centers.
Trends in the End-Use:
The hospitals segment accounted for the largest market share of 69.48% in 2024.
The ambulatory surgical centers segment is expected to grow at the fastest CAGR over the forecast period.
The regional segment includes North America, Europe, Asia Pacific, the Middle East and Africa, and Latin America.
In 2024, North America accounted for the highest aortic aneurysm market share at 46.25% and was valued at USD 2,479.44 Million and is expected to reach USD 4,802.00 Million in 2032. In North America, the U.S. accounted for the aortic aneurysm market share of 70.87% during the base year of 2024. Governments are encouraging individuals for early detection through routine screenings. This is for high-risk populations such as older adults and smokers. This leads to early detection and timely treatment. Moreover, healthcare facilities are incorporating new innovative products. This is to make treatments safer and more effective.
For instance,
Overall, increasing screenings programs and healthcare facilities adopting innovative products are driving the market in region.
In Asia Pacific, the aortic aneurysm market is experiencing the fastest growth with a CAGR of 10.6% over the forecast period. The risk of aneurysms also increased with aging population because aging weakens the blood vessels. This has led to a higher demand for diagnostic tests and treatments for aneurysms. Moreover, there is growing awareness about aneurysms in APAC. More people are learning about the symptoms and risks of aneurysms. This has led to the need in diagnosis and preventive treatments. Additionally, governments and medical organizations are working to educate the public, encouraging regular health checkups and screenings.
Europe's aortic aneurysm market analysis states that several factors are responsible for the progress of the market in the region. Manufacturers are introducing innovative stent grafts, minimally invasive devices, and robotic surgery tools in the region. These innovations are making treatments more effective and less invasive. These products are improving patient outcomes. Moreover, growing demand for minimally invasive surgery is another key driver in Europe. Procedures such as EVAR and TEVAR are gaining popularity. It is because they reduce recovery times and minimize pain. Additionally, governments in the region are introducing favorable initiatives to support the treatment of aneurysms.
The Middle East and Africa (MEA) aortic aneurysm market analysis states that the region is also witnessing several trends for notable surge. Advances in imaging technologies, such as CT scans, MRIs, and AI-based diagnostics are making it easier to detect aneurysms at an early stage. Early detection allows for timely treatment. Moreover, the growing prevalence of hypertension, smoking, and high blood pressure is driving the market in region. These factors damage the arteries, making individuals more vulnerable to developing aortic aneurysms. This is leading to increased demand for treatments.
Latin America's aortic aneurysm market size is also emerging. The expansion of ambulatory centers is driving the growth of the market in region. Ambulatory Surgical Centers (ASCs) offer minimally invasive procedures. These procedures are safer and less costly compared to traditional surgeries. These centers provide faster treatments, and shorter recovery times. Moreover, collaborations between healthcare providers, medical device companies, and governments are also boosting the market in the region. These partnerships are focused on improving access to treatments. They are also increasing awareness and enhancing medical research.
The Aortic Aneurysm market is highly competitive with major players providing products to the national and international markets. Key players are adopting several strategies in research and development (R&D) and product innovation to hold a strong position in the global Aortic Aneurysm market. Key players in The Aortic Aneurysm industry include-
Product Launch:
Report Attributes | Report Details |
Study Timeline | 2019-2032 |
Market Size in 2032 | USD 10,852.55 Million |
CAGR (2025-2032) | 9.3% |
By Type |
|
By Aneurysm Type |
|
By End-Use |
|
By Region |
|
Key Players |
|
North America | U.S. Canada Mexico |
Europe | U.K. Germany France Spain Italy Russia Benelux Rest of Europe |
APAC | China South Korea Japan India Australia ASEAN Rest of Asia-Pacific |
Middle East and Africa | GCC Turkey South Africa Rest of MEA |
LATAM | Brazil Argentina Chile Rest of LATAM |
Report Coverage |
|
In 2024, the Aortic Aneurysm market is USD 5,361.08 Million.
Asia-Pacific is the fastest-growing region in the Aortic Aneurysm market.
Type, Aneurysm Type, and End-Use segmentation details are covered in the Aortic Aneurysm market
Medtronic Plc (Ireland), Cook Medical (U.S.), Abbott Laboratories (U.S.), Terumo Corporation (Japan), Boston Scientific (U.S.), Getinge (Sweden), and Cardinal Health (U.S.) are some major players in the market.